The murky path to drug discovery in ALS becomes clearer
- PMID: 24067399
- DOI: 10.1016/S1474-4422(13)70224-2
The murky path to drug discovery in ALS becomes clearer
Erratum in
- Lancet Neurol. 2013 Dec;12(12):1133
Comment on
-
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.Lancet Neurol. 2013 Nov;12(11):1059-67. doi: 10.1016/S1474-4422(13)70221-7. Epub 2013 Sep 23. Lancet Neurol. 2013. PMID: 24067398 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous